CD36 and cancer: Treatment with sulfo-N-succinimidyl oleate (SSO), a competitive LCFA-CD36 binding blocker (24, 34), similarly reduced palmitate uptake (Figure 2F), confirming that LCFA uptake in cancer cells was promoted by CD36 in MCF7 cells.